Groundbreaking Dual-Target Alzheimer's vaccine enters human testing
NCT ID NCT07142278
Summary
This early-stage study will test the safety of an experimental Alzheimer's vaccine called DUVAX in 24 healthy adults aged 40-65. Participants will receive either the vaccine or a placebo injection to see how well it's tolerated and whether it triggers an immune response against Alzheimer's-related proteins. The goal is to determine if this vaccine approach is safe enough for further testing as a potential way to prevent Alzheimer's disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Palm Springs Community Health Center
Miami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.